Home » Topics » Regulatory » Patents

Patents
RSS

Potent nAChR receptor agonists with heterocyclic structure patented by Astra

March 1, 1999

Bayer claims oxazolidinones active against Gram-positive bacteria and mycobacteria

Feb. 26, 1999

CNS compounds from Merck acting on serotonergic system

Feb. 26, 1999

Fujisawa's new hypoglycemic and hypolipidemic agents

Feb. 26, 1999

Novel BK channel modulators developed at Bristol-Myers Squibb

Feb. 26, 1999

Azacycloalkane derivatives for diabetes and related disorders patented by Synthelabo

Feb. 26, 1999

NNRTIs from Boehringer Ingelheim effective against mutant viruses

Feb. 25, 1999

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

ICE/ced-3 cysteine protease inhibitors in development at Idun

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...